| abstract |
The present invention relates to methods, reagents and kits based on the combined detection of tumor-related autoantibodies and tumor markers. In the present invention, the combination of three or more tumor-related autoantibodies corresponding to antigen proteins and one or more tumor marker antibodies is used to optimize the design of detection reagents and kits, which greatly improves the sensitivity and accuracy of tumor diagnosis, and is particularly suitable for for early diagnosis of tumors. |